Mymetics Corp (MYMX): Virosome, a hybrid vehicle for efficient...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Sunday, 03/08/2020 10:20:42 PM

Sunday, March 08, 2020 10:20:42 PM

Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment

https://www.researchgate.net/publication/277413664_Virosome_a_hybrid_vehicle_for_efficient_and_safe_drug_delivery_and_its_emerging_application_in_cancer_treatment

Keep Last Read

Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM

InvestorsHub NewsWire

Only $200 per official company press release!